Screener
Mirum Pharmaceuticals, Inc. MIRM Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Exchange and repurchase of 2029 convertible notes | (474,365) | — |
| Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs of $8,600 | 259,948 | — |
| Proceeds from issuance of common stock pursuant to equity plans | 23,499 | 15,047 |
| Net cash provided by financing activities | 481,517 | 15,047 |
| Effect of exchange rate on cash, cash equivalents and restricted cash | (2,645) | 3,281 |
| Net increase in cash, cash equivalents and restricted cash | 34,297 | 5,674 |
| Cash, cash equivalents and restricted cash at beginning of period | 298,165 | 222,928 |
| Cash, cash equivalents and restricted cash at end of period | $332,462 | $228,602 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s financing cash flow?
- Mirum Pharmaceuticals, Inc. (MIRM) reported financing cash flow of $211.44M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s financing cash flow increased by 2333.7% year-over-year, from $8.69M to $211.44M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s financing cash flow has grown at a -14.0% compound annual growth rate (CAGR), from $73.47M to $40.14M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Mirum Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude